Academe Learn
CBME Curriculum Preview

Page 20 of 20

IM29.1-26 | The Role of the Physician in the Community — PBL Case

CLINICAL SETTING

Dr Anand is a 34-year-old postgraduate resident in the medicine ward of a government teaching hospital in Chennai. He has been working under significant personal stress for the past several months following a family bereavement and accumulated debts. His co-residents have noticed a pattern over the past six weeks: he is often late for morning rounds, his clinical notes have become brief and sometimes incomplete, and on two occasions colleagues have smelled alcohol on his breath when he comes in for night duty. On a Tuesday evening, Dr Anand's intern, Meera, observes him make an error in transcribing a drug prescription — he writes 'metformin 5g' instead of '500mg' for a newly admitted patient with type 2 diabetes. Meera corrects the prescription before it reaches the pharmacist and writes a note in the medication record without informing anyone else. The ward's consultant physician, Dr Rao, is aware that something is 'not right' with Dr Anand but has not addressed it formally, telling another resident: 'He's going through a rough patch — we don't want to ruin his career.' The following week, a newly enrolled research participant in the ward's diabetes registry study is consented by Dr Anand. She is a 58-year-old woman who speaks primarily Tamil and has limited formal education. Dr Anand conducts the entire consent process in English, does not use the Tamil participant information sheet prepared by the team, and does not complete the interpreter request form. She signs the consent form. Three days later, she tells Meera during a routine blood draw: 'I don't know what I agreed to. He talked fast in English and I just signed because I didn't want to be difficult.'

Trigger 1: The Prescribing Error and the Intern's Decision

Meera has corrected the metformin dose in the medication record and has not told anyone — not Dr Rao, not the head of the department, and not the patient. She reasons: 'No harm was done because I caught it in time. Reporting it will get Dr Anand into trouble when he is already struggling.' She asks a fellow intern for advice. The fellow intern says: 'You already fixed it — what is there to report?' Meera is unsatisfied with this answer but does not know the correct standard.

DISCUSSION POINTS

  • Under the documentation and risk management standards that apply to medical records (IM29.13, IM29.21), was Meera's decision to correct the prescription silently — without reporting the error — the correct professional response? What should have been documented, by whom, and in what format?
  • How does the principle of non-maleficence apply when harm was averted — does the near-miss still carry a professional reporting obligation, and if so, why?
  • What is the difference between a medication error that is corrected before harm reaches the patient (a near-miss) and an adverse event? Does the distinction alter the reporting obligation under patient safety frameworks?
Click to reveal Trigger 2: The Pattern of Impairment and the Institutional Silence (discuss previous trigger first!)

Trigger 2: The Pattern of Impairment and the Institutional Silence

After the research consent incident, Meera speaks privately to a senior resident, Dr Priya, who has also noticed the pattern over six weeks. Dr Priya says: 'We all see it. But no one wants to report him — he is our colleague, he is under stress, and reporting will destroy his career and his family situation. The consultant knows and has not acted. If the consultant isn't acting, why should we?' Meera reads IM29.24 from her NMC competency manual and finds: 'Identify, discuss and defend medico-legal, socio-cultural professional and ethical issues in dealing with Impaired physicians.' She asks Dr Priya: 'Does the institution have a process for this? And does professional loyalty actually protect us — or does it make us complicit?'

DISCUSSION POINTS

  • What does 'physician impairment' include under the medico-legal and ethical framework (IM29.24), and at what point does a pattern of behaviour cross from a personal difficulty into a patient-safety obligation to act?
  • Dr Rao's inaction constitutes what kind of failure — individual, supervisory, or systemic? How does the Swiss Cheese model help explain how Dr Anand's impairment persisted without being addressed?
  • Does professional loyalty ('not wanting to ruin a colleague's career') have any legitimate weight in the ethical analysis, or does it constitute a conflict of interest when patient safety is at risk? Frame your answer using the four-principle framework.
Click to reveal Trigger 3: The Research Consent That Was Not Informed (discuss previous trigger first!)

Trigger 3: The Research Consent That Was Not Informed

Meera reports the consent problem to Dr Priya, who asks the study's principal investigator, Dr Sharma, to review the situation. Dr Sharma reviews the consent form: the participant's signature is present, and the form is complete on its face. Dr Sharma says: 'The form is signed. This is technically valid consent.' Meera disagrees and says: 'She told me she did not understand what she was signing. She signed because she felt pressured, not because she was informed. Is a signed form the same as informed consent?' The research ethics committee's last review of this study was six months ago.

DISCUSSION POINTS

  • Is a signed consent form, in the absence of genuine understanding, legally and ethically valid under ICMR 2017 guidelines? What are the key elements of a valid informed consent that go beyond the signature?
  • The participant is illiterate in English (though not in Tamil) and felt socially pressured to sign. Under ICMR 2017 guidelines for vulnerable or low-literacy participants, what specific procedural safeguards were violated, and what must now be done?
  • What is the principal investigator's obligation when a consent process failure is identified after enrolment? Is the participant still enrolled in the study, and if so, on what terms? Does the incident need to be reported to the research ethics committee?
Click to reveal Trigger 4: Escalation, Documentation, and What Happens to Dr Anand (discuss previous trigger first!)

Trigger 4: Escalation, Documentation, and What Happens to Dr Anand

After the three incidents — the prescribing error, the six-week pattern of concern, and the defective consent — Meera decides she must act. She drafts an incident report and a separate note for Dr Rao. Dr Rao receives the report and calls Meera to his office. He acknowledges the seriousness and tells Meera: 'I will speak with Dr Anand and refer him to occupational health. I will also suspend his research consent duties pending review. The research ethics committee will be notified. But I want you to understand — this is about getting Dr Anand help, not destroying him.' Meera asks: 'What happens to the affected patient, the research participant, and the medical record of the prescribing error? And what about the period when all of us knew but did not report — are we protected?'

DISCUSSION POINTS

  • What documentation must now be created in the medical record for the prescribing error (even though harm was averted), in the research file for the defective consent, and in Dr Anand's occupational health referral? Apply IM29.13 to each.
  • Does a near-miss report made after a six-week delay, when the reporter was aware of the pattern throughout, affect the reporter's professional protection? How should institutions balance early reporting incentives with retrospective disclosure?
  • How should Dr Rao communicate the consent failure to the research participant? What information must she be given, what options must she be offered (re-consent, withdrawal without penalty), and who is responsible for ensuring this happens?

Group Task Assignments

  • Draft a structured near-miss report for the metformin prescribing error: include what happened, what was done, what could have happened, and what system change would prevent recurrence. Do not name Dr Anand — use the systems-based format.
  • Role-play the conversation in which a senior resident or consultant approaches Dr Anand about his impairment, with the goal of supporting his recovery and removing him from patient care duties temporarily — while preserving his dignity and professional future. Identify the ethical tensions in this conversation.
  • Design a corrective re-consent process for the research participant who signed without understanding: what information must be re-communicated, in what format, with what interpreter, and what must happen if she now wishes to withdraw?
  • Debate the proposition: 'A professional culture that prioritises loyalty over patient safety is more dangerous than an individual impaired physician.' Use the Swiss Cheese model to support your argument.

Learning Issues

Research these questions and bring your findings to the discussion.

  1. [IM29.24] What are the ethical and medico-legal obligations of a physician — at every seniority level — when they become aware of a colleague's impairment that may affect patient care?
  2. [IM29.26] What are the specific procedural requirements for valid informed consent under ICMR 2017, and how do these requirements change for participants with limited literacy or non-English language backgrounds?
  3. [IM29.21] What is a near-miss event, and what are the professional reporting obligations when a near-miss is identified and corrected before harm reaches the patient?
  4. [IM29.13] What documentation standards govern the recording of medication errors, near-misses, and corrective actions in the medical record, and how does late documentation (after a delay) affect the record's medico-legal standing?
  5. [IM29.1] When professional loyalty to a colleague conflicts with the duty of non-maleficence toward patients, which obligation prevails and why — and what institutional processes are designed to manage this conflict?